
Product name:Dipeptidyl Peptidase (DPP)-IV Inhibitor
Description:Dipeptidyl peptidase (DPP)-IV inhibitors, which act via enhancing the incretins,represent another new therapeutic approach to the treatment of type 2 diabetes.Glucagon-like peptide 1 (GLP-1) and glucose dependent insulinotropic peptide (GIP) account for the majority of incretin action7.



